Our data demonstrate that ETS-1 phosphorylation at T38 is unrelated to MEK/ERK pathways, which suggests that other potential kinases could phosphorylate ETS-1 at T38 in cisplatin resistant HNSCC. The gene discussed is ETS1; the disease is head and neck squamous cell carcinoma.